Unicycive Therapeutics (NASDAQ:UNCY - Get Free Report) released its earnings results on Thursday. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.13), Zacks reports.
Unicycive Therapeutics Stock Up 0.5 %
Shares of Unicycive Therapeutics stock traded up $0.00 during trading on Wednesday, hitting $0.55. The stock had a trading volume of 2,231,734 shares, compared to its average volume of 1,421,825. The company has a market capitalization of $56.93 million, a PE ratio of -0.57 and a beta of 2.26. Unicycive Therapeutics has a 1 year low of $0.20 and a 1 year high of $1.60. The stock has a 50 day simple moving average of $0.59 and a 200 day simple moving average of $0.57.
Analyst Ratings Changes
Separately, HC Wainwright raised their price objective on Unicycive Therapeutics from $4.00 to $7.50 and gave the stock a "buy" rating in a research note on Tuesday.
Get Our Latest Research Report on UNCY
About Unicycive Therapeutics
(
Get Free Report)
Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494, which is in Phase 1 clinical trials for treatment of acute kidney injury.
Further Reading
Before you consider Unicycive Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicycive Therapeutics wasn't on the list.
While Unicycive Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
